Singapore-based healthtech startup Injewelme has raised $1.2 million in a funding round led by Temasek, marking a significant step in its efforts to scale technology-driven healthcare solutions. The investment highlights continued interest in early-stage healthtech ventures that combine innovation with practical applications in patient care and wellness.
The newly secured funding will be used to accelerate product development and enhance the company’s platform capabilities. Injewelme is focused on leveraging technology to improve healthcare accessibility and personalization, positioning itself within a rapidly growing segment of digital health solutions.
With this round, the startup aims to strengthen its presence in Singapore while exploring opportunities for regional expansion. The company is expected to invest in building its technical infrastructure, expanding its team, and refining its offerings to better serve healthcare providers and end users.
The involvement of Temasek underscores confidence in the startup’s potential to address evolving healthcare needs through innovation. As healthcare systems increasingly adopt digital tools, early-stage companies like Injewelme are gaining traction by offering scalable and efficient solutions that align with modern patient expectations.
The funding also reflects a broader trend in Singapore’s startup ecosystem, where healthtech continues to attract strong investor interest. With increasing demand for digital healthcare services, startups operating in this space are expected to play a crucial role in shaping the future of healthcare delivery across the region.
As Injewelme moves forward with its growth plans, the company will focus on delivering impactful solutions that bridge technology and healthcare, aiming to improve outcomes while contributing to the ongoing digital transformation of the industry.
